Form 4: ABM Director Colleran's Equity Grant & Share Activity

Sentiment:

Statement of Changes in Beneficial Ownership (Form 4)


ABM Industries Director Donald F. Colleran reported an annual restricted stock unit grant and a related tax withholding share disposition.

Summary

  • Donald F. Colleran, a Director of ABM Industries Inc. /DE/, reported transactions on January 6, 2026.
  • Acquired 3,996 shares of Common Stock through an annual grant of restricted stock units (RSUs) under the 2021 Equity and Incentive Compensation Plan, with a transaction price of $0.0000 per share.
  • These RSUs represent a contingent right to receive shares and will vest on the first anniversary of the grant date, with dividend equivalent rights (DERs) accruing.
  • Disposed of 1,188 shares of Common Stock at a price of $43.79 per share, likely for tax withholding purposes related to the RSU vesting.
  • Following these transactions, beneficial ownership stands at 20,527 shares of Common Stock.
  • The reported beneficial ownership includes shares acquired pursuant to dividend reinvestment, which are exempt from Section 16 under Rule 16a-11.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to director compensation, including an RSU grant and a tax-related share disposition. These are standard events and do not indicate significant positive or negative sentiment regarding the company's performance or outlook.

Positives

  • Director Donald F. Colleran received an annual grant of 3,996 restricted stock units (RSUs), aligning his interests with shareholders.
  • The RSUs include dividend equivalent rights (DERs), providing additional value to the director.
  • Beneficial ownership includes shares acquired through dividend reinvestment, indicating a continued investment in the company.

Negatives

  • A disposition of 1,188 shares of Common Stock occurred at $43.79 per share, likely to cover tax obligations related to the RSU vesting.

Future Outlook

The RSUs granted on January 6, 2026, are scheduled to vest on the first anniversary of the grant date, which would be January 6, 2027.

Industry Context

This Form 4 filing reflects a routine compensation event for a non-employee director, common across publicly traded companies. Annual RSU grants are a standard component of director remuneration, designed to align director interests with long-term shareholder value. The subsequent sale of shares for tax withholding is also a typical practice when equity awards vest.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Compensation Plan UtilizationAnnual grant of restricted stock units to non-employee directors was made under the 2021 Equity and Incentive Compensation Plan.01/06/2026Reinforces the company's established equity compensation framework for non-employee directors, aligning their interests with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The RSU grant aligns director interests with shareholder value. The share disposition for tax purposes is a routine event and does not significantly impact the overall share structure or value.
  • Directors: Donald F. Colleran received additional equity compensation, reinforcing his stake in the company's future performance.

Next Steps

  • The 3,996 restricted stock units granted on January 6, 2026, are scheduled to vest on January 6, 2027.

Key Dates

DateDescription
01/06/2026Date of reported transactions (RSU grant and share disposition).
01/08/2026Signature date of the reporting person's power of attorney.

Keywords

ABM Industries, ABM, Form 4, insider transaction, director compensation, restricted stock units, RSU grant, equity compensation, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.